Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
about
Risk potentiality of frontline radiotherapy associated cataract in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma.Primary Sjögren's syndrome initially presenting as submandibular mucosa-associated lymphoid tissue lymphoma: A case report.Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.Comparison of American Joint Committee on Cancer TNM-based staging system (7th edition) and Ann Arbor classification for predicting outcome in ocular adnexal lymphoma.Ocular adnexal lymphoma: validation of American Joint Committee on Cancer seventh edition staging guidelines.Suggestion of response evaluation criteria in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML).Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification.Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma.Frontline treatment with chemoimmunotherapy for limited-stage ocular adnexal MALT lymphoma with adverse factors: a phase II studyClinical value of magnetic resonance imaging and other baseline testing for conjunctival mucosa-associated lymphoid tissue lymphoma.Intracranial relapse as a solitary mass of ocular adnexal lymphoma of the mucosa-associated lymphoid tissue type.Ophthalmologic outcomes after chemotherapy and/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma.Subtle CD20 positivity in the bone marrow of a patient who has a mucosa-associated lymphoid tissue lymphoma should not be regarded as evidence of involvement in the bone marrow.Can conjunctival lymphoma be a clinical diagnosis?
P2860
Q34889114-CFBB13AB-FA0D-4058-95AB-73EC5ACC2081Q36524135-D3BFADC4-FEAD-4F0A-B429-5D31D0FE419CQ38138170-18D9A1F2-5760-4ABD-B307-28639813EDBAQ38158237-4D046DB5-28EA-4D24-904E-64D0CBA0CAAAQ38206705-2286735C-4A2C-42B3-A5C8-6DCAAD908F7CQ38366528-0F98B672-8DF3-49D4-9ED8-21337A46DA58Q40938960-55D8FB42-92AF-4C23-8E2E-2FD0A744947EQ41691477-EF3CCAF9-5D9D-4A32-8A6E-B910EBE41E3AQ42366631-1172FAFA-6C2A-489D-912C-07494FCD2CDAQ44035481-D5DECFB5-4440-4670-9E69-1FD470D57500Q49322793-B3FE79C4-D5CD-4378-BAE3-6C7220CD767BQ51605001-07962ABA-6A91-4EFC-8736-816BBAB0F541Q53133469-B4CAFD6C-394C-42EC-8A7E-4D249BA6C6D1Q54487634-FA3C28CD-5708-44BA-AA93-9D1B0AD4DE72
P2860
Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Feasibility of the TNM-based s ...... mphoid tissue (MALT lymphoma).
@en
Feasibility of the TNM-based s ...... osa-associated lymphoid tissue
@nl
type
label
Feasibility of the TNM-based s ...... mphoid tissue (MALT lymphoma).
@en
Feasibility of the TNM-based s ...... osa-associated lymphoid tissue
@nl
prefLabel
Feasibility of the TNM-based s ...... mphoid tissue (MALT lymphoma).
@en
Feasibility of the TNM-based s ...... osa-associated lymphoid tissue
@nl
P2093
P2860
P356
P1476
Feasibility of the TNM-based s ...... mphoid tissue (MALT lymphoma).
@en
P2093
Byung-Ock Choi
Chang-Suk Kang
Ji-Sun Paik
Kyung-Sin Park
Sang-Nam Lee
Seok-Goo Cho
Seung-Eun Jung
Suk-Woo Yang
Sung-Eun Lee
Sung-Hoon Kim
P2860
P304
P356
10.1002/AJH.21963
P577
2011-02-15T00:00:00Z